RecruitingNCT06676137

An Observational Study of Coronary Microvascular Disease of China

China Coronary Microvascular Disease(CCMD) Registry


Sponsor

Henan Institute of Cardiovascular Epidemiology

Enrollment

500 participants

Start Date

Nov 11, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria3

  • Angina symptoms
  • Objective evidence of myocardial ischemia
  • Coronary angiography was normal,irregular tube wall, or stenosis <50%

Exclusion Criteria2

  • People under the age of 18
  • Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fuwai central China cardiovascular hospotial

Zhengzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06676137


Related Trials